Relationship between hand-foot skin reaction and external force on patients with hepatocellular carcinoma: A cohort study

被引:0
|
作者
Tahara, Yukie [1 ,3 ]
Amemiya, Ayumi [1 ]
Kase, Ryutaro [1 ]
Kitagawa, Yuka [1 ]
Ogasawara, Sadahisa [2 ]
Kato, Naoya [2 ]
Komiyama, Masatoshi [1 ]
机构
[1] Chiba Univ, Grad Sch Nursing, Dept Hlth Promot Nursing & Midwifery, Chiba, Japan
[2] Chiba Univ, Grad Sch Med, Dept Gastroenterol, Chiba, Japan
[3] Chiba Univ, Grad Sch Nursing, Dept Nursing Physiol, 1-8-1 Inohana,Chuo Ku, Chiba, Chiba 2608672, Japan
关键词
Drug therapy; Hepatocellular carcinoma; Friction; Pressure; Hand-foot syndrome; SORAFENIB; REGORAFENIB; PREVENTION; LENVATINIB; EFFICACY; SAFETY; TRIAL; RISK;
D O I
10.1016/j.ejon.2024.102576
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Hand-foot skin reaction (HFSR), a side effect of tyrosine kinase inhibitor (TKI) treatment, makes it difficult to walk and perform daily activities because of pain in the limbs. HFSR occurs predominantly in the sites where external forces (pressure and shear stress) are applied. This study aimed to determine whether pressure or shear stress induces the occurrence of HFSR. Methods: This cohort study was conducted in patients who received TKI treatment for hepatocellular carcinoma. The external forces applied to the sole of the patients' foot while walking was measured, and its association with the occurrence of HFSR was examined. The degree of HFSR was assessed by the patient's response during the examination and by photographs of their feet. The patients' feet were divided into low (grade <2) or high (grade >= 2) HFSR foot group, and the differences in external forces between the groups were analyzed using t -test and Cox hazard analysis. Results: Analysis of the feet of 55 study participants (n = 110) showed no significant difference between the groups on t -test (p >= 0.05), however, Cox hazard analysis showed an increased risk of HFSR with higher peak shear stress values at the fifth metatarsal head (hazard ratio = 1.01, p = 0.047; 95% confidence interval = 1.00-1.02). Conclusion: Shear stress is possibly related to HFSR occurrence. Nurses should assess whether patients' shoes fit their feet before initiating TKI treatment. They should instruct patients to wear shoes that are fit of both diameter and width for their feet.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Genetic predisposition of hand-foot skin reaction after sorafenib therapy in patients with hepatocellular carcinoma
    Lee, Joo Ho
    Chung, Young-Hwa
    Kim, Jeong A.
    Shim, Ju Hyun
    Lee, Danbi
    Lee, Han Chu
    Shin, Eun-Soon
    Yoon, Jung Hwan
    Kim, Byung Ik
    Bae, Si Hyun
    Koh, Kwang Cheol
    Park, Neung-Hwa
    CANCER, 2013, 119 (01) : 136 - 142
  • [2] Hand-foot skin reaction induced by sorafenib in a hepatocellular carcinoma patient
    Pathania, Yashdeep Singh
    POSTGRADUATE MEDICAL JOURNAL, 2020, 96 (1138) : 495 - 495
  • [3] Multikinase inhibitor-associated hand-foot skin reaction as a predictor of outcomes in patients with hepatocellular carcinoma treated with sorafenib
    Ochi, Masanori
    Kamoshida, Toshiro
    Ohkawara, Atsushi
    Ohkawara, Haruka
    Kakinoki, Nobushige
    Hirai, Shinji
    Yanaka, Akinori
    WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (28) : 3155 - 3162
  • [4] Hand-foot skin reaction is a beneficial indicator of sorafenib therapy for patients with hepatocellular carcinoma: a systemic review and meta-analysis
    Wang, Ping
    Tan, Gang
    Zhu, Mingxin
    Li, Weidong
    Zhai, Bo
    Sun, Xueying
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 12 (01) : 1 - 8
  • [5] Increased cumulative doses and appearance of hand-foot skin reaction prolonged progression free survival in sorafenib-treated advanced hepatocellular carcinoma patients
    Chang, Wen-Tsan
    Lu, Sheng-Nan
    Rau, Kung-Ming
    Huang, Ching-Shan
    Lee, King-Teh
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2018, 34 (07) : 391 - 399
  • [6] Multikinase inhibitor-associated hand-foot skin reaction as a predictor of outcomes in patients with hepatocellular carcinoma treated with sorafenib
    Masanori Ochi
    Toshiro Kamoshida
    Atsushi Ohkawara
    Haruka Ohkawara
    Nobushige Kakinoki
    Shinji Hirai
    Akinori Yanaka
    World Journal of Gastroenterology, 2018, (28) : 3155 - 3162
  • [7] Risk of hand-foot skin reaction with the novel multikinase inhibitor regorafenib: a meta-analysis
    Belum, Viswanath Reddy
    Wu, Shenhong
    Lacouture, Mario E.
    INVESTIGATIONAL NEW DRUGS, 2013, 31 (04) : 1078 - 1086
  • [8] Clinical characteristics, treatment outcomes, and prognosis in patients with MKIs-associated hand-foot skin reaction: a retrospective study
    Shou, Liumei
    Chen, Jialu
    Shao, Tianyu
    Zhang, Yao
    Zhao, Shuya
    Chen, Shuyi
    Shu, Qijin
    SUPPORTIVE CARE IN CANCER, 2023, 31 (07)
  • [9] Evaluation of hand-foot syndrome and hand-foot skin reaction: Case series
    Demirdag, Hatice Gamze
    Ayanoglu, Burcu Tugrul
    Armagan, Basak Yalici
    TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY, 2019, 53 (01): : 28 - 31
  • [10] Targeted therapy and hand-foot skin reaction in advanced renal cell carcinoma
    Yang, Chih-Hsun
    Chuang, Cheng-Keng
    Hsieh, Jia-Juan
    Chang, John Wen-Cheng
    EXPERT OPINION ON DRUG SAFETY, 2010, 9 (03) : 459 - 470